| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | Former Director | Common Stock | 18,595 | $106,735 | $5.74 | 21 May 2024 | Direct |
| Aurinia Pharmaceuticals Inc. | Former Director | Stock Option (right to buy) | 15,234 | 19 May 2023 | Direct | ||
| Aurinia Pharmaceuticals Inc. | Former Director | Restricted Stock Units | 0 | 18 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 09 Sep 2024 | 0 | $0 | 4 | Former Director | 20 Sep 2024, 16:56 |
| AUPH | Aurinia Pharmaceuticals Inc. | 21 May 2024 | 1 | -$32,316 | 4 | Director | 22 May 2024, 16:07 |
| AUPH | Aurinia Pharmaceuticals Inc. | 18 May 2023 | 5 | -$54,251 | 4 | Director | 23 May 2023, 17:16 |
| AUPH | Aurinia Pharmaceuticals Inc. | 18 May 2022 | 2 | $0 | 4 | Director | 20 May 2022, 16:09 |
| AUPH | Aurinia Pharmaceuticals Inc. | 09 Mar 2022 | 1 | +$54,985 | 4 | Director | 11 Mar 2022, 15:05 |
| AUPH | Aurinia Pharmaceuticals Inc. | 14 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 21:17 |
| AUPH | Aurinia Pharmaceuticals Inc. | 11 May 2021 | 4 | +$50,529 | 4 | Director | 13 May 2021, 16:17 |